ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.
ProPhase Labs, Inc. (PRPH)
US:NASDAQ Investor Relations:
prophaselabs.com/investors/annual-reports
Company Research
Source: GlobeNewswire
ProPhase Labs in discussions for strategic initiative to realize significant underlying value in the Company. Voting for Current Proxy Critically Important. Crown Medical Achieves Final Hurdle. Appointed Special Counsel to Launch Litigation Against Insurance Companies. First Settlement Completed. Reiterates $50 MILLION Net A/R Goal Next-Phase Commercialization of BE-Smart™ Underway Following Landmark Study Published in the Official Journal of the American College of Gastroenterology UNIONDALE, NY, Nov. 19, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”) today announced it is in M&A related discussions not connected to a crypto treasury strategy. These discussions, if successful, could potentially recognize the underlying value of ProPhase at multiples of its current share price. The Company believes meaningful value drivers, including the $50M Crown Medical collections initiative, commercialization of the BE-Smart™ Esophageal Cancer Test,
Show less
Read more
Impact Snapshot
Event Time:
PRPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRPH alerts
High impacting ProPhase Labs, Inc. news events
Weekly update
A roundup of the hottest topics
PRPH
News
- ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript [Seeking Alpha]Seeking Alpha
- ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ... [Yahoo! Finance]Yahoo! Finance
- Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on December 1 [Yahoo! Finance]Yahoo! Finance
- Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1GlobeNewswire
- ProPhase Labs, Inc. (PRPH) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
PRPH
Earnings
- 8/13/25 - Beat
PRPH
Sec Filings
- 11/26/25 - Form 8-K
- 11/25/25 - Form 8-K
- 11/25/25 - Form 8-K
- PRPH's page on the SEC website